Company profile for PAO Group

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

PAO Group, Inc has recently revitalized its mission to advance medical cannabis technologies with two complimenatry acquistions. One of a cannabis cultivation operation and one of a cannabis biopharmaceutical asset. The cannabis biopharmaceutical asset, RespRx, is derived from a patented botanical extraction process - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCL...
PAO Group, Inc has recently revitalized its mission to advance medical cannabis technologies with two complimenatry acquistions. One of a cannabis cultivation operation and one of a cannabis biopharmaceutical asset. The cannabis biopharmaceutical asset, RespRx, is derived from a patented botanical extraction process - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING ..." With the patented intellectual property (IP), to include the existing and ongoing research and development PAOG focuses on the development of pharmaceuticals to treat various illnesses, diseasesetc.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1180 Cleveland Road Sandusky, OH 44870
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-11-19/law90-launches-revolutionary-ai-positioning-program-expands-into-texas-market-and-announces-nation

PHARMIWEB
19 Nov 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/pao-group-inc-announces-new-ceo-james-schramm-1073361

ACCESSWIRE
15 Sep 2025

https://www.globenewswire.com/news-release/2022/02/03/2378767/0/en/PAOG-Expects-Increased-Visibility-For-Its-CBD-Nutraceuticals-From-USMJ-Ecommerce-Campaign.html

GLOBENEWSWIRE
03 Feb 2022

https://www.globenewswire.com/news-release/2022/02/01/2376879/0/en/PAOG-To-Expand-CBD-Nutraceutical-Sales-In-2022-And-Continue-Pharmaceuticals-Development.html

GLOBENEWSWIRE
01 Feb 2022
PAOG Publishes 2022 Strategic Update
PAOG Publishes 2022 Strategic Update

28 Jan 2022

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2022/01/28/2375266/0/en/PAOG-Publishes-2022-Strategic-Update.html

GLOBENEWSWIRE
28 Jan 2022

https://www.prnewswire.com/news-releases/paog-and-pura-announce-womens-health-cbd-product-partnership-301421216.html

PRNEWSWIRE
10 Nov 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty